Author

Lajos Kalmar

University of Cambridge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Andrew CraxtoniD· 1 shared Angela RubioiD· 1 shared Anne E. WillisiD· 1 shared Catarina de Matos Ferraz FrancoiD· 1 shared Catherine FickeniD· 1 shared David Fernández‐AntorániD· 1 shared Gorettu Munoz· 1 shared Ian R. PowleyiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Andrew CraxtonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

YBX3 overexpression in mesothelioma drives aberrant cell proliferation

Angela Rubio, Robert F. Harvey, Andrew Craxton, Mark R. Southwood, Catherine Ficken, Catarina de Matos Ferraz Franco, Lajos Kalmar, Gorettu Munoz, Ian R. Powley, Stephan Kamrad, Rui Guan, David Fernández‐Antorán, Kiran Raosaheb Patil, John P. C. Le Quesne, Marion MacFarlane, Anne E. Willis

This study identifies YBX3 as an oncoprotein in mesothelioma that drives cell proliferation through SLC7A5/LAT1-mediated amino acid uptake and shows JPH203 as a potential therapeutic agent.

Cell Death and Disease · Oct 30, 2026Peer-reviewedMolecular Biology